Phencyclidine induces D-1 dopamine receptor mediated Fos-like immunoreactivity in discretely localised populations of striatopallidal and striatoentopeduncular neurons in the rat

Brain Research

Volumn 821, Issue 1, 1999, Pages 177-189

  Griffiths, M R ^a   Mitchell, I J ^a   Cooper, A J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Apoptosis; c fos FLI; N Methyl D aspartate; Phencyclidine; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COLLOIDAL GOLD; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; ENTOPEDUNCULAR NUCLEUS; GENE EXPRESSION; GLOBUS PALLIDUS; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; BRAIN; CORPUS STRIATUM; EXCITATORY AMINO ACID ANTAGONISTS; GLOBUS PALLIDUS; GOLD COLLOID; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; NEURONS; PHENCYCLIDINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 0033528424     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01120-8     Document Type: Article

References (79)

1. R.L. Albin, A. Reiner, K.D. Anderson, J.B. Penney, A.B. Young, Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia, Ann. Neurol. 27 (1990) 357-365.
2. H.W. Berendse, Galis-de Graaf, H.J. Groenewegen, The topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat, J. Comp. Neurol. 316 (1992) 314-347.
3. V. Bernard, B. Dumartin, E. Lamy, B. Bloch, Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat, Eur. J. Neurosci. 5 (1993) 1218-1225.
4. S. Berretta, H.A. Robertson, A.M. Graybiel, Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum, J. Neurophysiol. 68 (1992) 767-777.
5. R.J. Boegman, S.R. Vincent, Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol, Synapse 22 (1996) 70-77.
6. 1 and sigma, receptor subtypes, Neuroscience 76 (1997) 467-477.
7. A.J. Cooper, M. Fraser, M. Foreshaw, D.J. Barber, I.J. Mitchell, Acute administration of D-1 dopamine agonists and a D-2 antagonist induce apoptosis of a sub-population of striatal neurons, Brain Res. Assoc. Abstr. 14 (1997) 58.
8. A.J. Cooper, I.J. Mitchell, Fos immunopositive neurons in the subthalamic nucleus following reversal of Parkinsonian symptoms by antagonism of excitatory amino acid transmission in the entopeduncular nucleus of the monoamine depleted rat, Neurosci. Lett. 201 (1995) 25-254.
9. A.J. Cooper, B. Moser, I.J. Mitchell, A subset of striatopallidal neurons are Fos-immunopositive following acute monoamine depletion in the rat, Neurosci. Lett. 187 (1995) 189-192.
10. A.J. Cooper, S. Wooller, I.J. Mitchell, Elevated striatal Fos immunoreactivity following 6-hydroxydopamine lesioning of the rat is mediated by excitatory amino acid transmission, Neurosci. Lett. 194 (1995) 73-76.
11. K. Davison, C.R. Bagley, Schizophrenia-like psychoses associated with organic cerebral disorders - a review, Pscyhiatr. Dev. 1 (1969) 1-34.
12. V. Deroche, P.V. Piazza, S. Maccari, M. Le Moal, H. Simon, Repeated corticosterone administration sensitizes the locomotion response to amphetamine, Brain Res. 584 (1992) 309-313.
13. G. Di Chiara, M. Morelli, S. Consolo, Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions, Trends Neurosci. 17 (1994) 228-233.
14. D. Diorio, V. Viau, M.J. Meaney, The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress, J. Neurosci. 13 (1993) 3847-3859.
15. G. Ellison, Competitive and non-competitive NMDA antagonists induce similar limbic degeneration, NeuroReport 5 (1994) 2688-2692.
16. G. Ellison, The NMDA antagonists phencyclidine, ketamine and dizocilpine as both behavioural and anatomical models of dementias, Brain Res. Rev. 20 (1995) 250-267.
17. N.B. Farber, M.T. Price, J. Labruyere, J. Nemnich, H. St. Peter, D.F. Wozniak, J.W. Olney, Antipsychotic-drugs block phencyclidine receptor-mediated neurotoxicity, Biol. Psychiatry 34 (1993) 119-121.
18. N.B. Farber, D.F. Wozniak, M.T. Price, J. Labruyere, J. Huss, H.S. Peter, J.W. Olney, Age-specific neurotoxicity in the rat associated with NMDA receptor blockade - potential relevance to schizophrenia, Biological Psychiatry 38 (1995) 788-796.
19. J.M. Finlay, M.J. Zigmond, The effects of stress on central dopaminergic neurons: possible clinical implications, Neurochem. Res. 22 (1997) 1387-1394.
20. C.R. Gerfen, K.G. Baimbridge, J.J. Miller, The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey, Proc. Natl. Acad. Sci. 82 (1985) 8780-8784.
21. C.R. Gerfen, The neostriatal mosaic: multiple levels of compartmental organisation, Trends Neurosci. 15 (1992) 133-139.
22. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science 250 (1990) 1429-1432.
23. C.R. Gerfen, K.A. Keefe, E.B. Gauda, D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons, J. Neurosci. 15 (1995) 8167-8176.
24. 3H]dopamine release from rat striatal slices by sigma receptor ligands, J. Pharmacol. Exp. Ther. 271 (1994) 212-219.
25. A.M. Graybiel, Neurotransmitters and neuromodulation in the basal ganglia, Trends Neurosci. 13 (1990) 244-258.
26. A.M. Graybiel, M.J. Besson, E. Weber, Neuroleptic sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat, J. Neurosci. 9 (1989) 326-338.
27. A.M. Graybiel, R. Moratalla, H.A. Robertson, Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA 87 (1990) 6912-6916.
28. T. Hamamura, Y. Ichimaru, Amphetamine sensitization augments amphetamine-induced Fos expression in the lateral habenula, Brain Res. 767 (1997) 140-143.
29. R.J. Handa, K.M. Nunley, M.R. Bollnow, Induction of c-fos mRNA in the brain and anterior pituitary gland by a novel environment, NeuroReport 4 (1993) 1079-1082.
30. K. Hashimoto, S. Tomitaka, N. Narita, Y. Minabe, M. Iyo, S. Fukui, Induction of heat shock protein (HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of sigma receptor ligands, Addict. Biol. 1 (1996) 61-70.
31. T.G. Hastings, D.A. Lewis, M.J. Zigmond, Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections, Proc. Natl. Acad. Sci. USA 93 (1996) 1956-1961.
32. J.C. Hedreen, S.E. Folstein, Early loss of neostriatal striosome neurons in Huntington's disease, J. Neuropathol. Exp. Neurol. 54 (1995) 105-120.
33. D.L. Helmreich, W.E. Cullinan, S.J. Watson, The effect of adrenalectomy on stress-induced c-fos mRNA expression in the rat brain, Brain Res. 706 (1996) 137-144.
34. P. Hertel, J.M. Mathe, G.G. Nomikos, M. Iurlo, A.A. Mathe, T.H. Svensson, Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat, Behav. Brain Res. 72 (1995) 103-114.
35. K. Ismail, S. Wessely, Psychiatric complications of corticosteroid therapy, Br. J. Hosp. Med. 53 (1995) 495-499.
36. D.C. Javitt, S.R. Zukin, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry 148 (1991) 1301-1308.
37. Y. Kawaguchi, Neostriatal cell subtypes and their functional roles, Neurosci. Res. 27 (1997) 1-8.
38. Y. Kawaguchi, C.J. Wilson, S.J. Augood, P.C. Emson, Striatal interneurons: chemical, physiological and morphological characterization, Trends Neurosci. 18 (1995) 527-535.
39. K.A. Keefe, C.R. Gerfen, D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors, J. Comp. Neurol. 367 (1996) 165-176.
40. T. Kobayaski, K. Matsuno, M. Murai, S. Mita, Sigma-1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain, Neurochem. Res. 22 (1997) 1105-1109.
41. G.J. LaHoste, J. Yu, J.F. Marshall, Striatal Fos expression is indicative of D1/D2 synergism and receptor supersensitivity, Proc. Natl. Acad. Sci. 90 (1993) 7451-7455.
42. 1 dopamine receptor gene, Proc. Natl. Acad. Sci. 88 (1991) 4205-4209.
43. C. Le Moine, E. Normand, A.F. Guitteny, B. Fouque, R. Teoule, B. Bloch, Dopamine receptor gene expression by enkephalin neurons in rat forebrain, Proc. Natl. Acad. Sci. 87 (1990) 230-234.
44. C. Le Moine, P. Svenningsson, B. Fredholm, B. Bloch, Dopamine-adenosine interactions in the striatum and globus pallidus: inhibition of striatopallidal neurons through either D2 or A2a receptors enhances D1 receptor-mediated effects on c-fos expression, J. Neurosci. 17 (1997) 8038-8048.
45. S.M. Lillrank, W.T. O'Connor, P. Saransaari, U. Ungerstedt, In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats, Acta Physiol. Scand. 150 (1994) 109-115.
46. I. Liste, M.J. Guerra, H.J. Caruncho, J.L. Labandeira-Garcia, Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors, Exp. Brain Res. 115 (1997) 458-469.
47. A.J. McGeorge, R.L.M. Faull, The organisation of the projection from the cerebral cortex to the striatum in the rat, Neuroscience 29 (1989) 503-537.
48. I.J. Mitchell, A.C. Cooper, M.R. Griffiths, D.J. Barber, Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis?, Neuroscience 84 (1998) 489-501.
49. I.J. Mitchell, S. Lawson, B. Moser, S.M. Laidlaw, A.J. Cooper, G. Walkinshaw, C.M. Waters, Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat, Neuroscience 63 (1994) 1-5.
50. R. Nakki, F.R. Sharp, S.M. Sagar, FOS expression in the brainstem and cerebellum following phencyclidine and MK-801, J. Neurosci. Res. 43 (1996) 203-212.
51. R. Nakki, F.R. Sharp, S.M. Sagar, J. Honkaniemi, Effects of phencyclidine on immediate early gene expression in the brain, J. Neurosci. Res. 45 (1996) 13-27.
52. K. Nishijima, A. Kashiwa, A. Hashimoto, H. Iwama, A. Umino, T. Nishikawa, Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis, Synapse 22 (1996) 303-312.
53. J.W. Olney, N.B. Farber, Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity, J. Clin. Psychiatry 55 (1994) 43-46.
54. J.W. Olney, J. Labruyere, M.T. Price, Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science 244 (1989) 1360-1362.
55. J.W. Olney, J. Labruyere, G. Wang, D.F. Wozniak, M.T. Price, M.A. Sesma, NMDA antagonist neurotoxicity: mechanism and prevention, Science 254 (1991) 1515-1518.
56. A. Parent, S. Gravel, R. Boucher, The origin of forebrain afferents to the habenula in rat, cat and monkey, Brain Res. Bull. 6 (1980) 23-38.
57. J.R. Pauly, S.F. Robinson, A.C. Collins, Chronic corticosterone administration enhances behavioural sensitization to amphetamine in mice, Brain Res. 620 (1993) 195-202.
58. M.C. Raff, B.A. Barres, J.F. Burne, H.S. Coles, Y. Ishizaki, M.D. Jacobson, Programmed cell death and the control of cell survival: lesson from the nervous system, Science 262 (1993) 695-700.
59. L.P. Reagen, B.S. McEwen, Controversies surrounding glucocorticoid-mediated cell death in the hippocampus, J. Chem. Neuroanat. 13 (1997) 149-167.
60. A. Reiner, R.L. Albin, K.D. Anderson, C.J. D'Amato, J.B. Penney, A.B. Young, Differential loss of striatal projection neurons in Huntington's disease, Proc. Natl. Acad. Sci. USA 85 (1988) 5733-5737.
61. C. Rouillard, S. Bovetto, J. Gervais, D. Richard, Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine, Mol. Brain Res. 37 (1996) 105-115.
62. S.M. Sagar, F.R. Sharp, T. Curran, Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science 240 (1988) 1328-1331.
63. R.L. Sapolsky, L.C. Krey, B.S. McEwen, Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging, J. Neurosci. 5 (1985) 1222-1227.
64. D. Sato, A. Umino, K. Kaneda, M. Takigawa, T. Nishikawa, Developmental changes in distribution patterns of phencyclidine-induced c-fos in rat forebrain, Neurosci. Lett. 239 (1997) 21-24.
65. J.R. Seckl, 11β-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?, Front. Neuroendocrinol. 18 (1997) 49-99.
66. F.R. Sharp, S.M. Sagar, K. Hicks, D. Lowenstein, K. Hisanaga, c-fos mRNA, Fos, and fos-related antigen induction by hypertonic saline and stress, J. Neurosci. 11 (1991) 2321-2331.
67. J.W. Sharp, Phencyclidine (PCP) acts at σ sites to induce c-fos gene expression, Brain Res. 758 (1997) 51-58.
68. M. Sheng, M.E. Greenberg, The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron 4 (1990) 477-485.
69. T. Shinkai, S.A. Zhang, S.A. Mathias, G.S. Roth, Dopamine induces apoptosis in cultured rat striatal neurons; possible mechanism of D2-dopamine receptor neuron loss during aging, J. Neurosci. Res. 47 (1997) 393-399.
70. R.J. Smeyne, M. Vendrell, M. Hayward, S.J. Baker, G.C. Miao, K. Schilling, L.M. Robertson, T. Curran, J.I. Morgan, Continuous c-fos expression precedes programmed cell death in vivo, Nature 363 (1993) 166-169.
71. M.S. Sonders, J.F.W. Keana, E. Weber, Phencyclidine and psychomimetic sigma opiates: recent insights into their biochemical and physiological sites of action, Trends Neurosci. 11 (1988) 37-40.
72. D.C. Sterio, The unbiased estimation of number and sizes of arbitrary particle using the dissector, J. Microsc. 134 (1984) 127-136.
73. N. Tilakaratne, E. Friedman, Genomic response to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain, Eur. J. Pharmacol. 307 (1996) 211-217.
74. T.W. Vickroy, K.M. Johnson, Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices, J. Pharmacol. Exp. Ther. 223 (1982) 669-674.
75. 3H]BTCP): a new phencyclidine analogue selective for the dopamine uptake complex, Eur. J. Pharmacol. 148 (1988) 427-436.
76. D. Ward, A. Trevor, Phencyclidine-induced alterations in rat muscarinic cholinergic receptor regulation, Eur. J. Pharmacol. 74 (1981) 189-193.
77. A.H. Wyllie, Apoptosis: cell death in tissue regulation, J. Pathol. 153 (1987) 313-316.
78. R. Zilka-Falb, I. Ziv, N. Nardi, D. Offen, E. Melamed, A. Barzilai, Monoamine-induced apoptotic neuronal cell death, Cell. Mol. Neurobiol. 17 (1997) 101-118.
79. I. Ziv, E. Melamed, N. Nardi, D. Luria, A. Achiron, D. Offen, A. Barzilai, Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenetic mechanism in Parkinson's disease, Neurosci. Lett. 170 (1994) 136-140.